KTM
- Product code
- KTM
- Device name
- C3-Indirect Immunofluorescent Solid Phase
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.5240
- Medical specialty
- Immunology
- Marketing pathway
- 510(K)
- Flag
- Third-party review eligible
Official FDA classification page: KTM
Classification and pathway per current FDA publications. Data from openFDA (CC0).